Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Request for unlocking the Sample Page of the GLP-1 agonists Market DelveInsights Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape and Market Forecast - 2036 report delivers an in-depth understanding of Glucagon-like Peptide-1 (GLP-1) Agonists, addressable patient pool, competitive landscape, and future market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan
Methods We used a combination of glucagon secretion measurements in mouse and human islets (including islets from donors with type 2 diabetes), total internal reflection fluorescence microscopy imaging of secretory granule dynamics, recordings of cytoplasmic Ca 2+ and measurements of protein kinase A activity, immunocytochemistry, in vivo physiology and GTP-binding protein dissociation studies to explore how GLP-1 exerts its inhibitory effect on glucagon secretion and the role of the metabolite GLP-1(936)
doi: 10.1007/s11154-022-09724-x, 29
Certified upon completion signed certificate included at no extra cost
For weight loss, the main options are Wegovy (semaglutide), Saxenda (liraglutide), and Mounjaro (tirzepatide)
US$ 26.80
US$ 24.09
US$ 22.86
